Cancer news

Latest news, press releases and blog posts from Cancer Research UK.

Targeted Therapies

Some people with advanced kidney cancer could avoid surgery

The targeted drug sunitinib is as effective alone as when it’s combined with surgery for some people with advanced kidney cancer.

Six months of breast cancer treatment ‘could be as effective as 12’ in some women with early stage disease

Six months of treatment could be as effective as 12 months for women with a type of early stage breast cancer, according to unpublished clinical trial results.

Precision drug could treat different cancers with rare gene fault  

A new targeted drug could be used to treat a small number of advanced cancers no matter where they grow in the body, according to new trial results.

Breast cancer drug approved for NHS in England

A drug for certain types of breast cancer has been approved for the NHS in England.

Two clinical trials show promise with different targeted drugs for lung cancer

Two drugs targeting different gene faults in lung cancer have shown potential to be better than those already available.

Ovarian cancer drug reduces chance certain advanced breast cancers will get worse

A drug that’s already approved to treat certain ovarian cancers holds some advanced breast cancers at bay longer than standard chemotherapy.

Gold nanoparticles help deliver lethal one-two punch to cancer

Tagging gold nanoparticles with a small dose of radiation has helped researchers trace the precious metal as it delivers a drug into the heart of cancer cells.

New research provides hope for patients with hard-to-treat breast cancer

Cancer Research UK scientists have found a new way to slow the growth of the most aggressive type of breast cancer.

Defining cancers based on genetic ‘fingerprint’ could help personalise treatment

Doctors are closer to personalising treatment for some cancers as genetic analysis of tumours becomes more commonplace.

US hospital commits to lung cancer ‘liquid biopsy’

Analysing tumour DNA in blood samples could help doctors offer ‘targeted’ treatments best suited to a patient’s lung cancer.

Pages